RADLY (Raia Drogasil) EV-to-EBIT : 15.30 (As of May. 19, 2025)

Raia Drogasil EV-to-EBIT Chart

Raia Drogasil Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					50.65	34.44	25.55	29.23	20.12

Raia Drogasil Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															26.00	24.81	22.86	20.12	18.75

Competitive Comparison of Raia Drogasil's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Raia Drogasil's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raia Drogasil's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's EV-to-EBIT falls into.

Raia Drogasil EV-to-EBIT Calculation

Raia Drogasil's EV-to-EBIT for today is calculated as:

Raia Drogasil's current Enterprise Value is $5,762 Mil.
Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $377 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil  (OTCPK:RADLY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Raia Drogasil's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Raia Drogasil's Enterprise Value for the quarter that ended in Mar. 2025 was $7,548 Mil.
Raia Drogasil's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $377 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Raia Drogasil Business Description